JENNIE MERCHANT: Open Payments
NPI 1396262911 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 19 payments from 10 companies in 2025. Trend: 2023 $252 · 2024 $87 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $137 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Organogenesis Inc. | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Janssen Biotech, Inc. | 2 | $36 |
| Arcutis Biotherapeutics, Inc. | 1 | $26 |
| Almirall LLC | 1 | $26 |
| Biofrontera Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| KYOWA KIRIN, INC. | 1 | $14 |
Products named: Bimzelx, APLIGRAF, TREMFYA, LIBTAYO, Zoryve, Klisyri, AMELUZ, DUPIXENT.
Industry payments across FL — which companies pay providers there.
